ARCHIVES

Final Results from CLEOPATRA Phase III Trial Show Perjeta Increased OS 15.7 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 9 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: Names Submitted For NIH Deputy Director; Gottesman Leads Genome Project Temporarily

May 8, 1992

Cancer Letter Skips Next Two Weeks

September 2, 1988

Hospitals Win Grants For Radiation Oncology Disparity Research.

January 3, 2003

100 NSABP Sites May Enroll Patients; Only One Trial Open

July 15, 1994

In Brief: Willis Taylor New ACS President, Gerald Murphy President Elect, Robert Gadberry Bord Chairman

November 19, 1982

FDA Discloses Avastin Regulatory History.

December 14, 2007